Article in the 2017-May's edition of the PDA Letter:

Pharma Has its Head in the Cloud

Big Data is Leading Pharma Manufacturing to Greater Maturity

Yet from a regulatory perspective, there  are some risks that deserve special consideration.  ese are: the security and privacy  of the data, the commitment and quality  behind service level agreements, data  integrity, and disaster recovery processes.  Nevertheless, each of these elements can  be addressed by building on the strength  of cloud technologies. Many common  cloud platforms even feature their own  cybersecurity, such as Amazon, Google,  or Microsoft platforms. Now, consider a  manufacturer that has installed sensors  to feed data into an AI system to help  improve process performance. How can  that manufacturer address the risks?

Program available in this link.
www.pda.org/pdaletter. May 2017. Volume LIII, Issue 5